{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:45:43Z","timestamp":1791852343720,"version":"4.3.4"},"reference-count":22,"publisher":"Georg Thieme Verlag KG","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Endocrinol Diabetes"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Various predictors of overall mortality like hypopituitarism and treatment have been demonstrated in pituitary adenomas. Whether these predictors are specific to tumor subtype was not studied. We aimed to directly compare predictors of mortality in clinically significant pituitary adenoma subtypes (acromegaly, Cushing\u2019s disease, macroprolactinomas and non-functioning pituitary macroadenomas).<\/jats:p>\n                  <jats:p>We retrospectively analyzed all patients with acromegaly (n=224), Cushing\u2019s disease (n=42), macroprolactinoma (n=123) and non-functioning pituitary macroadenomas (n=310) admitted in our department between 2011 and 2025. The following variables were retrieved: sex, age and maximum tumor diameter at diagnosis, hypopituitarism and radiotherapy.<\/jats:p>\n                  <jats:p>Age and tumor size at diagnosis and rates of hypopituitarism and radiotherapy varied considerably between 38 and 57 years (macroprolactinomas vs. non-functioning pituitary macroadenomas), 7 and 25 mm (Cushing\u2019s disease vs. macroprolactinomas), 25 and 47% (acromegaly vs. non-functioning pituitary macroadenomas) and 6 and 38% (macroprolactinomas vs Cushing\u2019s disease), respectively. Univariate analysis showed that age at diagnosis was positively associated with mortality in all pituitary adenoma subtypes while hypopituitarism was both negatively (hazard ratio=0.37, acromegaly) and positively (hazard ratio=2.71, non-functioning pituitary macroadenomas) correlated with mortality. In multivariate analysis, age at diagnosis remained a consistent predictor (hazard ratio between 1.07 and 1.11) of overall mortality across the entire cohort. Cushing\u2019s disease was significantly associated with mortality while hypopituitarism predicted mortality only in non-functioning pituitary macroadenomas (hazard ratio=2.71). Sex, tumor size at diagnosis and radiotherapy were not associated with mortality.<\/jats:p>\n                  <jats:p>We confirmed that age is the main predictor of mortality in pituitary adenomas with a similar hazard ratio across all subtypes. Hypopituitarism was associated with an increased mortality only in those with non-functioning macroadenomas.<\/jats:p>","DOI":"10.1055\/a-2970-2015","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:15:55Z","timestamp":1790637355000},"source":"Crossref","is-referenced-by-count":0,"title":["Predictors of Overall Mortality in Pituitary Adenomas"],"prefix":"10.1055","author":[{"given":"Iustin D.","family":"Toma","sequence":"additional","affiliation":[{"name":"University of Medicine and Pharmacy Carol Davila Bucharest, Bucharest, Romania","place":["Bucharest"],"department":["Department of Endocrinology"]},{"name":"National Institute of Endocrinology C. I. Parhon, Bucharest, Romania","place":["Bucharest"],"department":["First Endocrinology Department"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6439-3523","authenticated-orcid":false,"given":"Dan A.","family":"Niculescu","sequence":"additional","affiliation":[{"name":"University of Medicine and Pharmacy Carol Davila Bucharest, Bucharest, Romania","place":["Bucharest"],"department":["Department of Endocrinology"]},{"name":"National Institute of Endocrinology C. I. Parhon, Bucharest, Romania","place":["Bucharest"],"department":["First Endocrinology Department"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raluca A.","family":"Trif\u0103nescu","sequence":"additional","affiliation":[{"name":"University of Medicine and Pharmacy Carol Davila Bucharest, Bucharest, Romania","place":["Bucharest"],"department":["Department of Endocrinology"]},{"name":"National Institute of Endocrinology C. I. Parhon, Bucharest, Romania","place":["Bucharest"],"department":["First Endocrinology Department"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona A.","family":"G\u0103loiu","sequence":"additional","affiliation":[{"name":"University of Medicine and Pharmacy Carol Davila Bucharest, Bucharest, Romania","place":["Bucharest"],"department":["Department of Endocrinology"]},{"name":"National Institute of Endocrinology C. I. Parhon, Bucharest, Romania","place":["Bucharest"],"department":["First Endocrinology Department"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u0103t\u0103lina","family":"Poian\u0103","sequence":"additional","affiliation":[{"name":"University of Medicine and Pharmacy Carol Davila Bucharest, Bucharest, Romania","place":["Bucharest"],"department":["Department of Endocrinology"]},{"name":"National Institute of Endocrinology C. I. Parhon, Bucharest, Romania","place":["Bucharest"],"department":["First Endocrinology Department"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/nov189","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012","volume":"17","author":"Q T Ostrom","year":"2015","journal-title":"Neuro Oncol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1530\/EJE-15-0189","article-title":"The epidemiology of pituitary adenomas in Iceland, 1955\u20132012: a nationwide population-based study","volume":"173","author":"T T Agustsson","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"101309","DOI":"10.1016\/j.beem.2019.101309","article-title":"The burden of disease for pituitary patients","volume":"33","author":"N R Biermasz","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s11102-020-01084-6","article-title":"Incidence, mortality, and cardiovascular diseases in pituitary adenoma in Korea: a nationwide population-based study","volume":"24","author":"J S Oh","year":"2021","journal-title":"Pituitary"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1530\/EJE-18-0255","article-title":"Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis","volume":"179","author":"F Bolfi","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1530\/EJE-15-0967","article-title":"Mortality in patients with non-functioning pituitary adenoma is increased: systematic analysis of 546 cases with long follow-up","volume":"174","author":"G Ntali","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s12020-022-03275-6","article-title":"Trends in incidence and mortality risk for acromegaly in Norway: a cohort study","volume":"80","author":"C M Falch","year":"2022","journal-title":"Endocrine"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s11102-023-01343-2","article-title":"Complications and mortality of Cushing\u2019s disease: report on data collected over a 20-year period at a referral centre","volume":"26","author":"A Mondin","year":"2023","journal-title":"Pituitary"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1348972","DOI":"10.3389\/fendo.2024.1348972","article-title":"High mortality risk among women with acromegaly still persists","volume":"15","author":"S G\u0103loiu","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s40618-023-02257-3","article-title":"Disease control of acromegaly does not prevent excess mortality in the long term: results of a nationwide survey in Italy","volume":"47","author":"M Arosio","year":"2024","journal-title":"J Endocrinol Invest"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1210\/jendso\/bvac045","article-title":"Increased mortality persists after treatment of cushing\u2019s disease: a matched nationwide cohort study","author":"D Bengtsson","year":"2022","journal-title":"J Endocr Soc"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1007\/s40618-024-02356-9","article-title":"Excess mortality in patients with non-functioning pituitary adenoma: a systematic review and meta-analysis","volume":"47","author":"F Bioletto","year":"2024","journal-title":"J Endocrinol Invest"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.1210\/jc.2009-1097","article-title":"ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly","volume":"94","author":"M Sherlock","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/cen.13141","article-title":"ACTH and gonadotropin deficiencies predict mortality in patients treated for nonfunctioning pituitary adenoma: long-term follow-up of 519 patients in two large European centres","volume":"85","author":"M W O\u2019Reilly","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1530\/ERC-16-0106","article-title":"Mortality in acromegaly: a 20-year follow-up study","volume":"23","author":"E Ritvonen","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s40618-024-02519-8","article-title":"Diagnostic delay, older age, and hormonal levels at diagnosis affect disease burden and mortality in acromegaly","volume":"48","author":"V Gasco","year":"2024","journal-title":"J Endocrinol Invest"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1007\/s40618-024-02303-8","article-title":"Different tumor growth pattern of clinically nonfunctioning pituitary neuroendocrine tumor according to sex and age: a longitudinal study","volume":"47","author":"S S Park","year":"2024","journal-title":"J Endocrinol Invest"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1530\/ERC-17-0253","article-title":"Acromegaly at diagnosis in 3173 patients from the Li\u00e8ge Acromegaly Survey (LAS) database","volume":"24","author":"P Petrossians","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1007\/s12020-024-04073-y","article-title":"Comparative mortality in pituitary adenomas subtypes: a tertiary referral center study","volume":"87","author":"I D Toma","year":"2024","journal-title":"Endocrine"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1210\/jc.2015-1475","article-title":"Excess mortality in women and young adults with nonfunctioning pituitary adenoma: a Swedish Nationwide Study","volume":"100","author":"D S Olsson","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"15155","DOI":"10.1038\/s41598-021-94658-8","article-title":"Incidence, demographics, and survival of patients with primary pituitary tumors: a SEER database study in 2004\u20132016","volume":"11","author":"C Chen","year":"2021","journal-title":"Sci Rep"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3171\/JNS\/2008\/108\/4\/0736","article-title":"Long-term recurrence and mortality after surgery and adjuvant radiotherapy for nonfunctional pituitary adenomas","volume":"108","author":"E F Chang","year":"2008","journal-title":"J Neurosurg"}],"container-title":["Experimental and Clinical Endocrinology &amp; Diabetes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2970-2015.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:51:48Z","timestamp":1791849108000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2970-2015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":22,"URL":"https:\/\/doi.org\/10.1055\/a-2970-2015","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0947-7349","1439-3646"],"issn-type":[{"value":"0947-7349","type":"print"},{"value":"1439-3646","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9,28]]},"published":{"date-parts":[[2026,9,28]]}}}